greeksoup/ stock research

Intuitive Surgical (ISRG) Q3 FY2023 earnings: revenue $1.7 billion, up 12.0% on the year

Intuitive Surgical Inc. (ISRG) reported revenue of $1.7 billion for Q3 FY2023, the quarter ended 30 September 2023, up 12.0% on the same quarter a year earlier. Net income was $416 million, up 28.3% on the year, and diluted earnings per share $1.16. The figures are the company's own, from the 10-Q it filed with the SEC on 20 October 2023.

Revenue
$1.7 billion
+12.0% on the year · -0.7% on the quarter
Q4 FY2021Q3 FY2023
Operating margin
26.7%
25.6% a year earlier
Q4 FY2021Q3 FY2023
Net income
$416 million
+28.3% on the year · -1.2% on the quarter
Q4 FY2021Q3 FY2023
Diluted EPS
$1.16
+28.9% on the year · -1.7% on the quarter
Q4 FY2021Q3 FY2023

this quarterthe same quarter a year earlierHover a bar for its figure.

Income statement (profit and loss)

$ millionQ3 FY2023Q2 FY2023Q3 FY2022On the quarterOn the yearLast 8 quarters
Revenue1,7441,7561,557-0.7%+12.0%
Cost of revenue576584505-1.3%+14.1%
Gross profit1,1671,1721,052-0.4%+10.9%
Gross margin66.9%66.7%67.6%
Research and development249244217+2.0%+14.9%
Selling, general and administrative452464436-2.6%+3.6%
Operating income466463399+0.6%+16.8%
Operating margin26.7%26.4%25.6%
Pre-tax income522499403+4.6%+29.6%
Income tax10273.278.1+39.6%+30.9%
Effective tax rate19.6%14.7%19.4%
Net income416421324-1.2%+28.3%
Net margin23.8%24.0%20.8%
Diluted EPS$1.16$1.18$0.90-1.7%+28.9%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionQ3 FY2023Q2 FY2023Q3 FY2022On the quarterOn the yearLast 8 quarters
Operating cash flow548666383-17.6%+43.1%
Capital expenditure256178169+43.7%+51.6%
Free cash flow292487214-40.1%+36.4%
Free cash flow margin16.8%27.8%13.7%
Cash from investing-447558544
Cash from financing61.863.3-927-2.4%
Share-based compensation157148139+6.0%+13.3%
Buybacks0.00.01,000
Dividends paid0.0n/an/a
Diluted shares, weighted358m357m360m+0.3%-0.6%
Shares outstanding at period end352m351m353m+0.2%-0.4%

Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.

Balance sheet

$ millionQ3 FY2023Q2 FY2023Q3 FY2022On the quarterOn the yearLast 8 quarters
Shareholders' equity12,53911,87911,515+5.6%+8.9%
Non-controlling interest84.580.658.6+4.8%+44.2%
Debt0.00.00.0
Other liabilities2,0891,9441,687+7.5%+23.9%
Total liabilities and equity14,71313,90313,261+5.8%+10.9%
Fixed assets3,0772,8312,244+8.7%+37.1%
Goodwill348349348-0.1%-0.0%
Intangible assets41.847.257.1-11.4%-26.8%
Investments3,9193,6965,854+6.0%-33.1%
Cash and equivalents3,6023,4351,538+4.8%+134.2%
Receivables963904850+6.5%+13.3%
Inventory1,1481,005837+14.2%+37.1%
Other assets1,6151,6361,533-1.3%+5.3%
Total assets14,71313,90313,261+5.8%+10.9%

Questions

What was Intuitive Surgical's revenue in Q3 FY2023?

Intuitive Surgical (ISRG) reported revenue of $1.7 billion for Q3 FY2023, the quarter ended 30 September 2023, up 12.0% on the same quarter a year earlier.

How much did Intuitive Surgical earn in Q3 FY2023?

Net income for Q3 FY2023 was $416 million, up 28.3% on the year, and diluted earnings per share $1.16.

When did Intuitive Surgical report Q3 FY2023 results?

Intuitive Surgical filed its 10-Q for the quarter ended 30 September 2023 with the SEC on 20 October 2023.

Quarterly results, the last 20 quarters

Q4 FY2021Q1 FY2022 †Q2 FY2022Q3 FY2022Q4 FY2022 *Q1 FY2023Q2 FY2023Q3 FY2023Q4 FY2023 *Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024 *Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025 *Q1 FY2026Q2 FY2026Q3 FY2026
Revenue1,5511,4881,5221,5571,6551,6961,7561,7441,9281,8912,0102,0382,4142,2532,4402,5052,8662,7712,8923,049
Cost of revenue490478499505544583584576651645637664771796822843962940932964
Gross profit1,0611,0101,0231,0521,1111,1131,1721,1671,2771,2451,3731,3741,6421,4581,6181,6621,9041,8301,9602,084
Gross margin68%68%67%68%67%66%67%67%66%66%68%67%68%65%66%66%66%66%68%68%
R&D183210207217244245244249260284280286295316313329353362371408
SG&A427391418436494480464452567492525511613563561573687613618633
Operating income450408398399372388463466450469567577735578743760864855972593
Operating margin29%27%26%26%23%23%26%27%23%25%28%28%30%26%30%30%30%31%34%19%
Pre-tax income4544024074033954224995225165386546718106688328559569401,055668
Tax rate16%8%23%19%15%14%15%20%-18%-2%19%15%15%-5%20%17%16%12%22%22%
Net income381366308324325355421416606545527565686698658704795822818523
Net margin25%25%20%21%20%21%24%24%31%29%26%28%28%31%27%28%28%30%28%17%
Diluted EPS$1.03$1.00$0.85$0.90$0.91$1.00$1.18$1.16$1.69$1.51$1.46$1.56$1.88$1.92$1.81$1.95$2.21$2.28$2.29$1.49
Operating cash flow5682234473834383716665482282656207068235827158418929121,0611,224
Capital expenditure15193.6130169138194178256436242309248312117155105162103113113
Free cash flow417129316214300177487292-20723.53114595114655607367308099481,111
Buybacks0.01065001,0001,0013500.00.066.30.00.00.00.00.01811,9132011,1233202,976
Dividends paidn/an/an/an/an/an/an/a0.0n/an/an/a0.0n/an/an/a0.0n/an/an/an/a
Shares outstanding358m359m357m353m350m350m351m352m352m355m355m356m357m358m358m355m355m354m354m347m
Filing10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q
Each quarter as filed, linked to its filing.
Read more* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS, and its diluted share count where shown, are from the company's results press release for that quarter, checked against the company's filed figures or a second data source. A quarter marked † is shown as the company last restated it in a later filing, so it compares with the quarters around it on one basis; rest on a figure for the one first filed. EPS is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

10-Q for the period ended 30 September 2023, filed 20 October 2023: the filing.